Array ( [0] => Array ( [acf_fc_layout] => text_editor_block [text_editor] => Call for applications – Scientific Manager Location: Geneva, Switzerland with frequent travels up to 25% of the working time Working time: 100% – possibility to work from home up to 50% of working time, or according to MPP HR rules. Contract: permanent The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. MPP’s initial work began with infectious diseases including HIV, viral hepatitis and TB, and obtained licences that resulted in high public health impact. In 2018, MPP’s mandate expanded to target medicines included in the WHO Model List of Essential Medicines or with potential for future inclusion, which encompass a whole range of disease areas, including diabetes and cancers. Additionally, MPP has the mandate to work on COVID-19 interventions, and is exploring other areas of intervention, as relevant. Finally, given their ground-breaking potential impact, long-acting technologies and formulations to achieve longer exposure to medicines is a focus area. For more information, please see our website, https://medicinespatentpool.org/ Scientific Manager at MPP performs a critical role of guiding MPP’s work through medical and technical advice in all aspects of its work. Working closely with international organisations and other stakeholders, including industry partners, the Scientific Manager is part of an MPP team dedicated to helping speed up access to better and adapted medicines for those in developing countries that need them most. The position reports to the Head of Scientific Information and works closely with a second scientific manager within the Science Unit. Main Duties/Responsibilities Core Responsibilities include:
Location: Geneva, Switzerland with frequent travels up to 25% of the working time
Working time: 100% – possibility to work from home up to 50% of working time, or according to MPP HR rules.
Contract: permanent
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.
MPP’s initial work began with infectious diseases including HIV, viral hepatitis and TB, and obtained licences that resulted in high public health impact. In 2018, MPP’s mandate expanded to target medicines included in the WHO Model List of Essential Medicines or with potential for future inclusion, which encompass a whole range of disease areas, including diabetes and cancers. Additionally, MPP has the mandate to work on COVID-19 interventions, and is exploring other areas of intervention, as relevant. Finally, given their ground-breaking potential impact, long-acting technologies and formulations to achieve longer exposure to medicines is a focus area.
For more information, please see our website, https://medicinespatentpool.org/
Scientific Manager at MPP performs a critical role of guiding MPP’s work through medical and technical advice in all aspects of its work. Working closely with international organisations and other stakeholders, including industry partners, the Scientific Manager is part of an MPP team dedicated to helping speed up access to better and adapted medicines for those in developing countries that need them most.
The position reports to the Head of Scientific Information and works closely with a second scientific manager within the Science Unit.
Core Responsibilities include:
MPP’s richness lies in its staff: a small dynamic and multicultural team!
To flourish in our team, you must recognise yourself in our values: Respect, Courage, Generosity and Commitment.
Moreover, the scientific manager will need to demonstrate the following qualities:
The MPP respects all individuals regardless of race, gender, ethnicity, sexual orientation, religion or disability.
This post is based in Geneva, Switzerland.
If you recognise yourself in this description and wish to join our outstanding team, please send a cover letter and C.V. to recruitment@medicinespatentpool.org including “scientific manager” as reference in the subject line by 19 September 2022.
Département communication, presse et médias
Le Medicines Patent Pool (MPP) est une organisation de santé publique soutenue par les Nations Unies, dont la mission est d’améliorer l’accès à des médicaments essentiels dans les pays à revenu faible et intermédiaire, et de faciliter la mise au point de tels médicaments. Au travers de son modèle économique innovant, le MPP collabore avec la société civile, les gouvernements, des organisations internationales, l’industrie, des groupes de patients et d’autres acteurs afin d’établir des priorités, de délivrer des licences sur les médicaments indispensables et de centraliser les actifs de propriété intellectuelle pour faciliter la fabrication de médicaments génériques et l’élaboration de nouvelles formulations.
À ce jour, le MPP a signé des accords avec 22 titulaires de brevets pour 13 antirétroviraux contre le VIH, une plateforme technologique sur le VIH, trois antiviraux à action directe contre l’hépatite C, un traitement contre la tuberculose, un traitement contre le cancer, quatre technologies à action prolongée, un traitement de l’hémorragie du post-partum, trois traitements antiviraux oraux contre la COVID-19 et 16 technologies liées à la COVID-19.
MPP a été fondé par Unitaid, qui continue d’être le principal bailleur de fonds de MPP. Le travail de MPP sur l’accès aux médicaments essentiels est également financé par l’Agence suisse pour le développement et la coopération (SDC), le gouvernement du Canada, l’Organisation mondiale de la propriété intellectuelle (OMPI) et le gouvernement de la Flandre. Les activités de MPP dans le cadre de la COVID-19 sont entreprises avec le soutien financier du gouvernement japonais, du ministère français de l’Europe et des Affaires étrangères, de l’Agence allemande de coopération internationale et de la SDC.